STOXPO
  • Latest News
  • Technology
    • Software
    • Semiconductors
  • Healthcare
    • Biotechnology
    • Pharmaceuticals
  • Crypto
    • Altcoins
    • Bitcoin
    • Ethereum
  • Companies
    • Micro-Cap
    • Small-Cap
    • Mid-Cap
    • Large-Cap
    • Mega-Cap
  • Q&A’s
  • Contributions
No Result
View All Result
  • Latest News
  • Technology
    • Software
    • Semiconductors
  • Healthcare
    • Biotechnology
    • Pharmaceuticals
  • Crypto
    • Altcoins
    • Bitcoin
    • Ethereum
  • Companies
    • Micro-Cap
    • Small-Cap
    • Mid-Cap
    • Large-Cap
    • Mega-Cap
  • Q&A’s
  • Contributions
No Result
View All Result
STOXPO
No Result
View All Result
Home Healthcare Biotechnology
chemistry

HCW Biologics Gains FDA Clearance for First-in-Human Trial of Novel Alopecia Areata Treatment

byLuca Blaumann
February 3, 2025
in Biotechnology, Small-Cap
Reading Time: 2 mins read
Share on TwitterShare on LinkedIn

Phase 1 Trial of HCW9302 Marks a Milestone in Autoimmune Disease Research

HCW Biologics (HCWB), a clinical-stage biopharmaceutical company specializing in innovative immunotherapies, has announced FDA clearance for its Investigational New Drug Application (IND) to begin a first-in-human Phase 1 clinical trial of HCW9302. This trial will evaluate the drug’s safety and efficacy in patients suffering from moderate-to-severe alopecia areata, an autoimmune disease characterized by sudden hair loss and a significant impact on psychological well-being.

HCW9302 is a groundbreaking interleukin 2 (IL-2) fusion protein complex developed using HCW’s proprietary TOBI platform technology. It functions by binding to IL-2αβγ receptors, primarily found on regulatory T (Treg) cells, which helps activate and expand these cells to suppress harmful immune and inflammatory responses. This mechanism offers hope for patients who currently have no FDA-approved curative treatments for alopecia areata.

Preclinical models have demonstrated HCW9302’s efficacy in treating autoimmune diseases at well-tolerated doses, showing potential beyond alopecia areata. The injectable, subcutaneous approach aims to reduce inflammation while minimizing the risk of broad immunosuppression.

Dr. Hing C. Wong, Founder and CEO of HCW Biologics, expressed enthusiasm about the FDA’s decision, stating, “This clearance brings us one step closer to offering a transformative immunotherapeutic for autoimmune diseases. While alopecia areata is not life-threatening, its psychological toll is profound, and current treatments often carry severe side effects.”

The primary goal of the Phase 1 trial is to establish a safe and effective dose of HCW9302 that boosts Treg cell activity. Success in this phase could lead to expanded trials targeting other autoimmune and inflammatory conditions, including graft rejection, atherosclerosis, diabetes, and neurodegenerative diseases.

Read original press release here

You might like this article:Trump’s New Tariffs Spark Global Retaliation and Trade War Fears

Tags: BreakingGrowthMoversNewsStock Market
Previous Post

Trump’s New Tariffs Spark Global Retaliation and Trade War Fears

Next Post

Palantir Reports Record Q4 Results, Solidifies Role in AI Revolution

Related Posts

Praxis Announces Breakthrough Phase 3 Results for Ulixacaltamide in Essential Tremor Treatment

byLuca Blaumann
October 16, 2025
0

Positive data from Essential3 program marks major step toward first targeted therapy for millions living with essential tremor Praxis Precision...

chemistry

Genprex Shares Gain as Positive Preclinical Lung Cancer Data to Be Presented at Global Oncology Conference

byLuca Blaumann
October 15, 2025
0

REQORSA® gene therapy shows promise against hard-to-treat ALK-positive non-small cell lung cancer Clinical-stage gene therapy developer Genprex (GNPX) announced that...

investing

Wall Street’s Biggest Analyst Calls Today: Upgrades Favor Tech, Downgrades Hit Industrials and Healthcare

byLiliana Vida
October 14, 2025
0

Semiconductor optimism drives bullish calls on AMD and Monolithic Power while managed care stocks come under pressure Wall Street analysts...

Next Post

Palantir Reports Record Q4 Results, Solidifies Role in AI Revolution

Latest News

Bitcoin Slides Toward $100,000 as Market Volatility Tests Investor Confidence

Praxis Announces Breakthrough Phase 3 Results for Ulixacaltamide in Essential Tremor Treatment

United Airlines Soars on Customer Loyalty and Strategic Investments as Profits Outpace Expectations

Genprex Shares Gain as Positive Preclinical Lung Cancer Data to Be Presented at Global Oncology Conference

Australian Oilseeds Holdings Surges on Strong Export Demand and Rising Global Vegetable Oil Prices

Based on Your Interest

investing
Artificial Intelligence

Wall Street’s Biggest Analyst Calls Today: Upgrades Favor Tech, Downgrades Hit Industrials and Healthcare

October 14, 2025
mining
Energy

U.S. Rare Earth Stocks Surge as Trade Tensions With China Escalate

October 13, 2025
Artificial Intelligence

OpenAI Doubles Down on Custom AI Chips in Landmark Broadcom Partnership

October 13, 2025

Recommended

Biotechnology

J&J Eyes Biotech Buyout to Strengthen Immunology Pipeline

October 10, 2025
Mid-Cap

KULR Technology Partners with Soluna to Launch Sustainable Bitcoin Mining Operations

October 9, 2025
Artificial Intelligence

Verizon Partners with AST SpaceMobile to Deliver Space-Based Cellular Coverage

October 8, 2025
Biotechnology

Envoy Medical Advances to Final Stage of FDA Trial for Fully Implanted Cochlear Implant

October 7, 2025
Asset Management

Tech Rally Lifts S&P 500 and Nasdaq as AMD Soars on OpenAI Deal

October 6, 2025
Stoxpo

Follow us on social media:

Highlights

  • Bitcoin Slides Toward $100,000 as Market Volatility Tests Investor Confidence
  • Praxis Announces Breakthrough Phase 3 Results for Ulixacaltamide in Essential Tremor Treatment
  • United Airlines Soars on Customer Loyalty and Strategic Investments as Profits Outpace Expectations
  • Genprex Shares Gain as Positive Preclinical Lung Cancer Data to Be Presented at Global Oncology Conference
  • Australian Oilseeds Holdings Surges on Strong Export Demand and Rising Global Vegetable Oil Prices

Category

  • Blog
  • Communication Services
    • Entertainment
    • Internet
    • Telecommunications
  • Companies
    • Large-Cap
    • Mega-Cap
    • Micro-Cap
    • Mid-Cap
    • Small-Cap
  • Consumer Cyclical
    • Auto Manufacturers
    • Casinos & Gambling
    • Ground Transportation
    • Hospitality
      • Casinp
      • Resorts & Lodging
      • Restaurants
      • Travel
        • Airlines
    • Retail
    • Textiles, Apparel & Luxury Goods
  • Consumer Defensive
    • Beverages
    • Discount Stores
    • Distributor
    • Ecommerece
    • Electrical Equipment
    • Foods
    • Household & Personal Products
    • Leisure Products
    • Tobacco
  • Contributions
  • Crypto
    • Altcoins
    • Bitcoin
    • Ethereum
  • Economy
  • Energy
    • Electric
    • Oil & Gas
    • Renewables
  • Financial Services
    • Asset Management
    • Banks
    • Brokerages
    • Credit Services
    • Insurance
  • Healthcare
    • Biotechnology
    • Medical Devices
    • Pharmaceuticals
  • Industrials
    • Aerospace & Defense
    • Construction
    • Industrial Machinery
  • Materials
    • Building Materials
    • Chemicals
    • Gold
    • Mining
    • Silver
    • Steel
  • Q&A's
  • Real Estate
  • Technology
    • Artificial Intelligence
    • Computer Hardware
    • Consumer Electronics
    • Cybersecurity
    • IT Services
    • Semiconductors
    • Software
  • Utilities

Latest News

Bitcoin Slides Toward $100,000 as Market Volatility Tests Investor Confidence

October 17, 2025

Praxis Announces Breakthrough Phase 3 Results for Ulixacaltamide in Essential Tremor Treatment

October 16, 2025
airplane

United Airlines Soars on Customer Loyalty and Strategic Investments as Profits Outpace Expectations

October 15, 2025
  • About
  • Privacy Policy
  • Contact

© 2024 All Rights Reserved: STOXPO.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Read More

In case of sale of your personal information, you may opt out by using the link Do Not Sell My Personal Information

Accept Cookie Settings
Cookies are small text files that can be used by websites to make a user's experience more efficient. The law states that we can store cookies on your device if they are strictly necessary for the operation of this site. For all other types of cookies we need your permission. This site uses different types of cookies. Some cookies are placed by third party services that appear on our pages.
  • Always Active
    Necessary
    Necessary cookies help make a website usable by enabling basic functions like page navigation and access to secure areas of the website. The website cannot function properly without these cookies.
  • Marketing
    Marketing cookies are used to track visitors across websites. The intention is to display ads that are relevant and engaging for the individual user and thereby more valuable for publishers and third party advertisers.
  • Analytics
    Analytics cookies help website owners to understand how visitors interact with websites by collecting and reporting information anonymously.
  • Preferences
    Preference cookies enable a website to remember information that changes the way the website behaves or looks, like your preferred language or the region that you are in.
  • Unclassified
    Unclassified cookies are cookies that we are in the process of classifying, together with the providers of individual cookies.
Cookie Settings

Do you really wish to opt-out?

No Result
View All Result
  • Latest News
  • Healthcare
    • Biotechnology
    • Pharmaceuticals
  • Technology
    • Software
    • Semiconductors
  • Crypto
    • Bitcoin
    • Ethereum
    • Altcoins
  • Companies
    • Micro-Cap
    • Small-Cap
    • Mid-Cap
    • Large-Cap
    • Mega-Cap
  • Q&A’s
  • Contributions

© 2024 All Rights Reserved: STOXPO.